PsiOxus Therapeutics Ltd.
  1. Companies
  2. PsiOxus Therapeutics Ltd.
  3. Products
  4. PsiOxus - Model NG-XXX - Single or ...

PsiOxusModel NG-XXX - Single or Multi-Protein Therapeutics Medicine

SHARE

Novel transgene combinations. Our research team are developing a suite of viral vectors with new and innovative transgene inserts.

Most popular related searches

Our approach to treating cancer involves selective delivery of single or multi-protein therapeutics to tumors via an intravenously injected viral vector. These therapeutics act locally to reprogram the tumor microenvironment, providing new treatment options for patients with cancer.

Our novel class of medicines expand the potential of immunotherapy to applications beyond T cell-rich ‘hot’ tumors, with therapeutic potential as both single agent and in combination with current immuno-oncology agents